Overcoming the Choke Points in Semaglutide Side Chain Synthesis with Core Technologies to Enable Eff
To address the diverse process requirements in semaglutide side chain synthesis, Watson offers two intermediate options: Fmoc-AEEA (CAS: 166108-71-0) and AEEA-AEEA (CAS: 1143516-05-5). And Watson's Fmoc-Glu-OtBu (CAS: 84793-07-7) and Glu-OtBu (CAS: 45120-30-7) products achieve 99% purity, 99.5% Optical Purity and 0.1% single impurities.
https://www.youtube.com/watch?v=NmH3pxyd2os
https://www.youtube.com/watch?v=NmH3pxyd2os
Comments
Post a Comment